Kioson Komersial Indonesia Tbk vs Brigit Biofarmaka Teknologi Tbk. — how do they compare? Kioson Komersial Indonesia Tbk trades at Rp99 (market cap 110.81B, 29.99M 24h volume), while Brigit Biofarmaka Teknologi Tbk. trades at Rp240 (market cap 166.01B, 324K 24h volume). The key difference: Brigit Biofarmaka Teknologi Tbk. is the larger of the two by market cap, and Kioson Komersial Indonesia Tbk is more actively traded (29.99M versus 324K). Which is the better fit depends on your goals.
| KIOS | OBAT | |
|---|---|---|
Market Cap | 110.81B | 166.01B |
Volume | 29.99M | 324K |
Lot | 299.94K | 3.24K |
Turnover | 2.97B | 77.68M |
Average Price | 99 | 239.75 |
Value | 2.97B | 77.68M |
Indicative Equilibrium Price | 99 | 240 |
Indicative Equilibrium Volume | 3.34K | 1 |
Trailing returns across standard periods
Latest headlines on both assets
PT Kioson Komersial Indonesia Tbk (the Company), was established on June 29, 2015 based on Notarial Deed No. 55 of Rose Takarina, S.H.
Read more on KIOS →PT. Brigit Biofarmaka Teknologi Tbk. (the Company) was established based on Notarial Deed No. 103 dated December 14, 2015 of Yoerista Arya Megasari, S.H., M.Kn., Notary in Sukoharjo. The company starts production commercially in 2018.
Read more on OBAT →